ZYUS ZYUS Life Sciences Corporation

0.2796USD0.4000 CAD · TSXV0.00%Mkt Cap: 22.39M USDP/E: —

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose com…

Institutional holders1 on file

Key Statistics

Company
Market Cap22.39M USD
Enterprise Value39.04M USD
Revenue (TTM)261.44K USD
Gross Profit34.95K USD
Net Income (TTM)-15.19M USD
Revenue/Share0.0035 USD
Last Price0.2796 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.43
PEG—
EV/EBITDA-5.53
EV/Revenue149.32
P/S85.64
P/B-1.19
EPS (TTM)-0.17 USD
EPS (Forward)-0.20 USD
52W Range
0.209722% of range0.5243
52W High0.5243 USD
52W Low0.2097 USD
Profitability
Gross Margin12.35%
Oper. Margin-3039.84%
EBITDA Margin0.00%
Profit Margin-5365.68%
ROE102.89%
ROA-428.11%
ROIC—
ROCE—
Growth
Revenue Growth-32.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.45M USD
CapEx (TTM)7.69K USD
FCF Margin-1928.58%
FCF Yield-22.52%
Net Debt16.52M USD
Net Debt/EBITDA-2.34
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.75
Current Ratio0.04
Quick Ratio0.03
Book Value/Sh-0.23 USD
Cash/Share0.0021 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.80.07M
Float39.85M
Insiders51.82%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short141
Short (prev mo.)1.67K
Technical
SMA 500.3381 (-17.3%)
SMA 2000.3644 (-23.3%)
Beta0.20
S&P 52W Chg12.00%
Avg Vol (30d)7.00K
Avg Vol (10d)2.68K
Technical Indicators
RSI (14)42.7
MACD-0.0339
MACD Signal-0.0413
MACD Hist.+0.0074
BB Upper0.3794 USD
BB Middle0.2852 USD
BB Lower0.1910 USD
BB Width66.08%
ATR (14)0.0157 USD
Vol Ratio (20d)0.00x

About ZYUS Life Sciences (CVE: ZYUS)

›

ZYUS Life Sciences (CVE: ZYUS) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.

The shares were at 0.4000 CAD on 18 November 2026, down 42.9% over 52 weeks. Its 52-week range is 0.3000 CAD to 0.7500 CAD: the price is 46.7% below the high and 33.3% above the low.

Its market capitalisation is 32.03M CAD.

ZYUS Life Sciences reports return on equity of 102.9% and revenue down 32.5% year over year.

Its debt exceeds its cash by 23.64M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. The next earnings report is expected on 25 November 2026.